Cite

HARVARD Citation

    Tonelli, M. et al. (n.d.). CP-134 Analysys of therapeutic response and tolerability in patients treated with crizotinib in ALK positive NSCLC. European journal of hospital pharmacy. p. A59. [Online]. 
  
Back to record